PPT-Considerations for IRB Review of Cell-Based Therapies

D Craig Hooper PhD FNAI Professor of Cancer Biology SKCC TJU DouglasCHooperJeffersonedu Therapeutic Modalities Cancer immunotherapy Hematologic disorders nonmalignant Regenerative medicine. Stem cell based therapies are increasingly being utilized with promising results in both malignant and non-malignant disorders 1-3 . Three sources of cells have been used for haematopoietic reconst E. . Rial-Sebbag. and A. . Blasimme. Outline. Presentation of cells therapies and of the legal and ethical tensions in using them.. Presentation of the . Durisotto. case. Discussion on the ruling of the European Court of Human . Jay Tchakarov. Director of Product Management. HighRadius. www.highradius.com. Company Overview. Founded 2006. f. astest growing tech company. specialized expertise in credit operations. cloud-based and SAP-certified solutions. Shawn . Kise. , RN . bsn. , & . Whitney Dunbar, RN BSN. Complementary and Alternative Medicine (CAM) . in the Critical Care Arena . Objectives. Review the foundation of complementary and alternative therapies . Celgene: . Abraxane. (nearly ~$1B per year). Paclitaxel (small molecules) associated with albumin. . 1. Molecular Engineering - Examples. Genentech: Antibody . engineering. i.e., KBI Biopharma, etc., etc. Kendrew Leung. Case. A House Fire. Rescued from a house fire Marian is hospitalized with . second degree burns . extending deep into the dermis layers in her upper limbs. After three days in hospital during which time she has regular changes of her wound dressings, she is released home to the care of her sister who expresses confidence in her ability to maintain the needed dressing changes. With a keen interest in natural remedies Marian and her sister treat her burn wounds with honey. A few days later Marian begins to experience . 7July2017Distr GENERALENGLISH ONLYNomenclature schemesfor advanced therapiessubstances for gene therapies substances for cell therapiessubstances for cell-based gene therapiesand virus-based therapies Dr. John Kuruvilla. Princess Margaret Cancer Centre. Disclosures. Research Support. Canadian Cancer Society, . Leukemia. and Lymphoma Society Canada, Princess Margaret Cancer Foundation, Janssen, Roche, Astra Zeneca. Risks, Reviews, and Revelations. Corey R. Babb, D.O., FACOOG, IF, NCMP. Clinical Assistant Professor of Obstetrics and gynecology. Oklahoma State University college of osteopathic medicine. Conflict of Interests Disclosure . Part I. F. . Hosseinpanah. Obesity Research Center. Research Institute for Endocrine sciences. Shahid. . Beheshti. University. of Medical Sciences. November 23, 2014. The incretin effect. Up to 70% of post-glucose insulin secretion is due to the effects of incretins. Seq. Analysis Pipeline. Marmar. Moussa. Ion . Mandoiu. Computer . Science & Engineering Department. University of . Connecticut. Outline. Motivation and challenges. Locality sensitive imputation. Summary deck. 2. With over 7,000 medicines in development, the exciting new wave of medical innovation will play a key role in . addressing the challenges faced by patients and healthcare systems . Source: Health Advances analysis; Adis R&D Insight Database. March 2015, compiled by PhRMA. How they work and the future of medicine. Every cell has a set lifespan. After that lifespan has been reached, a cell undergoes apoptosis (programmed cell death). The life(span) of a cell. How does apoptosis work?. 2019 Cellular Therapy Summary Slides. 1. Timeline and Milestones of CT Registry. 2. 2017. 2015. 2016. 2018. Establish the CT Task Force. First CT Registry Annual Forum. NCI funded CT Registry Pilot.